In Global News: Cyclist Will Bike 50-Mile Race Two Months After Quintuple Bypass Surgery, AI Tool to Diagnose Non-Small Cell Lung Cancer, and On-Pump Versus Off-Pump CABG [1]
Patient Care and General Interest
A man who received quintuple bypass surgery in Little Rock, Arkansas, USA, plans to cycle a 50-mile race [3] only two months later.
A woman in Denver, Colorado, USA, was told she had 6-9 months to live after being diagnosed with Stage 3 lung cancer; however, after participating in clinical trials for lung cancer treatment [4], she is doing well 10 years later.
Drugs and Devices
A hospital in New Jersey, USA, is testing an artificial intelligence device designed to detect bleeding during endovascular procedures [5].
The US Food and Drug Administration has approved the PK Papyrus covered coronary stent system for the treatment of acute coronary artery perforations during PCI [6], the first device to be approved for this indication in 17 years.
A study by the New York University School of Medicine in New York City suggests that an artificial intelligence tool can diagnose non-small cell lung cancer types with 97 percent accuracy [7].
Research, Trials, and Funding
A paper published in the Irish Journal of Medical Science indicates that undetected cases of high cholesterol are adding to the incidence of cardiovascular disease [8], which is the greatest cause of death in Ireland.
A Journal of the American College of Cardiology study of off-pump versus on-pump CABG suggests that the on-pump approach provides superior long-term survival [9].